|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
2009-12-25
|
|
pubmed:databankReference |
|
|
pubmed:abstractText |
Brain metastases (BMs) are a common complication of non-small cell lung cancer (NSCLC). Because of historical data indicating a poor prognosis for patients with BM, few randomized phase III studies of advanced NSCLC have included patients with BM at presentation. Because the potential benefits of systemic therapy in patients with BM are uncertain, we analyzed data from a recent phase III study.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jan
|
|
pubmed:issn |
1556-1380
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
5
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
110-6
|
|
pubmed:meshHeading |
pubmed-meshheading:20035187-Adenocarcinoma,
pubmed-meshheading:20035187-Adenocarcinoma, Bronchiolo-Alveolar,
pubmed-meshheading:20035187-Aged,
pubmed-meshheading:20035187-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:20035187-Brain Neoplasms,
pubmed-meshheading:20035187-Carboplatin,
pubmed-meshheading:20035187-Carcinoma, Large Cell,
pubmed-meshheading:20035187-Carcinoma, Non-Small-Cell Lung,
pubmed-meshheading:20035187-Carcinoma, Squamous Cell,
pubmed-meshheading:20035187-Deoxycytidine,
pubmed-meshheading:20035187-Female,
pubmed-meshheading:20035187-Follow-Up Studies,
pubmed-meshheading:20035187-Humans,
pubmed-meshheading:20035187-Lung Neoplasms,
pubmed-meshheading:20035187-Male,
pubmed-meshheading:20035187-Neoplasm Recurrence, Local,
pubmed-meshheading:20035187-Neoplasm Staging,
pubmed-meshheading:20035187-Paclitaxel,
pubmed-meshheading:20035187-Prognosis,
pubmed-meshheading:20035187-Retrospective Studies,
pubmed-meshheading:20035187-Survival Rate,
pubmed-meshheading:20035187-Treatment Outcome
|
|
pubmed:year |
2010
|
|
pubmed:articleTitle |
Outcomes associated with brain metastases in a three-arm phase III trial of gemcitabine-containing regimens versus paclitaxel plus carboplatin for advanced non-small cell lung cancer.
|
|
pubmed:affiliation |
University of Maryland Greenebaum Cancer Center, Baltimore, Maryland 21201-1595, USA, medelman@umm.edu
|
|
pubmed:publicationType |
Journal Article,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Clinical Trial, Phase III
|
